thiophenes has been researched along with Wet Macular Degeneration in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, E; Chiang, A; Garg, SJ; Ho, AC; Hsu, J; Jenkins, TL; Mikhail, M; Obeid, A; Patel, SN; Shah, CP; Spirn, MJ; Vander, JF; Wibbelsman, TD; Wolfe, JD | 1 |
Byeon, SH; Kim, SS; Koh, HJ; Lee, CS; Lee, JH; Lee, SC | 1 |
1 trial(s) available for thiophenes and Wet Macular Degeneration
Article | Year |
---|---|
Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Chemotherapy, Adjuvant; Choroidal Neovascularization; Drug Combinations; Exudates and Transudates; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Ophthalmic Solutions; Placebos; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2020 |
1 other study(ies) available for thiophenes and Wet Macular Degeneration
Article | Year |
---|---|
EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE-TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Topics: Administration, Topical; Aged; Angiogenesis Inhibitors; Bevacizumab; Drug Combinations; Female; Follow-Up Studies; Humans; Intravitreal Injections; Macula Lutea; Macular Degeneration; Male; Ophthalmic Solutions; Ranibizumab; Retrospective Studies; Sulfonamides; Thiophenes; Timolol; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2019 |